Understanding the factors that increase the risk of night sweats while taking semaglutide can help you better manage this potential side effect
Managing Drug Interactions and Contraindications The management of potential interactions and contraindications involves a thorough patient history and ongoing monitoring
Compared with placebo, the mean pain score improved significantly more with high-dose ALC
Yes, you can discuss with your healthcare provider the possibility of switching to a branded version of semaglutide, which may offer more reliable dosing and safety standards
Side Effects and Safety Profile Common Side Effects Gastrointestinal effects are the most frequently reported adverse events in clinical trials: Nausea (reported by 1233% of participants depending on dose) Diarrhea (1223%) Constipation (611%) Vomiting (59%) Decreased appetite (considered both a therapeutic effect and side effect) Abdominal pain (58%) Dyspepsia/heartburn (58%) These effects are most common during dose escalation and typically improve within 24 weeks at each new dose level
Proposed mechanisms include the production of short-chain fatty acids (SCFAs) through fermentation of dietary fibre, which may stimulate L-cells to release GLP-1, and potential effects on intestinal barrier function and inflammation
